The risk of neurodevelopmental disorders following a Thimerosal-preserved DTaP formulation in comparison to its Thimerosal- reduced formulation in the vaccine adverse event reporting system (VAERS)
Year: 2014
Type: article
Study design: Observational Study
Language: English
Subfield: Toxicology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2186341566
